In Phase 3 trials (n=412), it produced a 15.2% reduction in visceral fat and a significant increase in IGF-1 (Falutz et al., JAMA 2007At French Peptides, it is available exclusively for research
Phase 3 trials, including NCT07232719 and NCT07035093, are currently underway with much larger participant pools
Beyond appetite suppression, GLP-1 RAs improve systemic glucose homeostasis through pancreatic and extra-pancreatic mechanisms
Optimal results are achieved in a series of six treatments, with a maintenance program and skincare regimen customized to each individual
doi: 10.1080/00207454.2021.1924707 108 HolstJJ
The FDAs alert stresses the importance of obtaining Ozempic through legitimate healthcare channels and pharmacies to ensure the safety and effectiveness of the medication